-
USD
Home
/
ARA 290*10vials
ARA 290*10vials
Research-grade ARA-290 (Cibinetide) is an 11-amino-acid linear peptide derived from the helix-B surface of erythropoietin (EPO).
Quantity
-
Detail
ARA-290 (Cibinetide) (PyroGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser) is a non-erythropoietic EPO derivative developed by Araim Pharmaceuticals. It selectively binds the innate repair receptor (IRR = EPOR-β common receptor complex) without increasing hemoglobin or red blood cell count.
Key Scientific Features
- High-purity ARA-290 (≥ 99% by HPLC/MS, acetate salt form)
- Verified 11-amino-acid sequence: pyroGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
- Lyophilized formulation for long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, amino acid analysis, and IRR binding assay
- Manufactured in GMP-aligned, ISO-compliant facilities
- Suitable for IRR activation and tissue-protection research models
Research Applications
- In vitro and preclinical IRR binding and selectivity studies
- Non-erythropoietic EPO derivative research
- Inflammatory pathway and cytokine research models (TNF-α, IL-6)
- Cell-based apoptosis and tissue-repair mechanism studies
-
Customer ReviewsNo comments